Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Operating Expenses | 6,970 | 7,685 | 8,103 | 5,741 | 6,558 |
| Operating Income | -6,970 | -7,685 | -8,103 | -5,741 | -6,558 |
| Interest Expense | 0 | 0 | 146 | 163 | 178 |
| Other Income | 11,224 | -940 | -486 | 15,595 | -4,768 |
| Pre-tax Income | 4,254 | -8,625 | -8,735 | 9,691 | -11,504 |
| Net Income Continuous | 4,254 | -8,625 | -8,735 | 9,691 | -11,504 |
| Net Income | $4,254 | $-8,625 | $-8,735 | $9,691 | $-11,504 |
| EPS Basic Total Ops | 0.12 | -0.90 | -0.90 | 1.32 | -1.26 |
| EPS Basic Continuous Ops | 0.11 | -0.90 | -0.92 | 1.33 | -1.26 |
| EPS Diluted Total Ops | -0.60 | -0.90 | -0.90 | -0.78 | 1.08 |
| EPS Diluted Continuous Ops | 0.19 | -0.90 | -0.92 | 1.26 | -1.17 |
| EBITDA(a) | $-6,598 | $-6,963 | $-7,926 | $-5,579 | $-6,382 |